Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Report
MX:VRTX Q3 2023 EPS Results
- Actual EPS
- MXN 75.81
- Consensus EPS
- MXN 73.10
- Beat/Miss
- Beat by +MXN 2.71
- One Year Ago EPS
- MXN 74.51
MX:VRTX Q3 2023 Revenue Results
- Actual Revenue
- MXN 46.09B
- Expected Revenue
- MXN 46.48B
- Beat/Miss
- Missed by -MXN 385.76M
- YoY Revenue Growth
- +9.33%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/06/2023
- Time
- After Close
- Conference Call
- Monday, November 6, 2023
MX:VRTX Upcoming Earnings
Vertex Pharmaceuticals's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
MX:VRTX Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:VRTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q4) | 87.85- | 93.46 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 89.5088.44 | 89.19 | -0.83% (-0.74) | |
| Aug 03, 2026 | 2026 (Q2) | 88.0987.89 | 83.99 | 4.65% (+3.90) | |
| May 04, 2026 | 2026 (Q1) | 78.8483.06 | 75.44 | 10.10% (+7.62) | |
| Feb 12, 2026 | 2025 (Q4) | 94.9793.46 | 73.95 | 26.38% (+19.51) | |
| Nov 03, 2025 | 2025 (Q3) | 84.9789.19 | 81.38 | 9.59% (+7.80) | |
| Aug 06, 2025 | 2025 (Q2) | 79.6783.99 | -238.39 | 135.23% (+322.38) | |
| May 05, 2025 | 2025 (Q1) | 80.2175.44 | 88.44 | -14.71% (-13.01) | |
| Feb 10, 2025 | 2024 (Q4) | 74.6273.95 | 78.04 | -5.24% (-4.09) | |
| Nov 04, 2024 | 2024 (Q3) | 75.7781.38 | 75.81 | 7.35% (+5.57) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
